Product Name | MF | CAS | Details |
---|
Brachynoside | C31H40O15 | 145898-87-9 | Details |
Ergosta-5,24(28)-dien-25,26,26,26,27,27,27-d7-3beta-ol | C28H39D7O | 209112-82-3 | Details |
Isodesmosine chloride | C24H40ClN5O8 | 10059-18-4 | Details |
3-(2-Propynyloxy)piperidine hydrochloride | C8H14ClNO | 1185301-44-3 | Details |
Neuroendocrine Regulatory Peptide-4 (human, mouse, rat) trifluoroacetate salt | C87H135N25O24 | 922704-18-5 | Details |
2-(4H-1,2,4-Triazol-4-yl)acetic acid | C4H5N3O2 | 110822-97-4 | Details |
5-Fluoro-4-nitro-1-phenyl-1H-pyrazole | C9H6FN3O2 | 1803607-95-5 | Details |
BAT antibody | Details |
1-[(1-Aminopropan-2-yl)oxy]-2-chlorobenzene hydrochloride | C9H13Cl2NO | 1021871-58-8 | Details |
N,N-Dimethyl-2-chloroacetamide | C4H8ClNO | 2675-89-0 | Details |
Ac-g-Endorphin | C85H133N19O28S | Details |
2-Bromo-N-(2-methoxyethyl)acetamide | C5H10BrNO2 | 174215-37-3 | Details |
H-VEIFYR^-OH | Details |
1-{1-[(tert-Butoxy)carbonyl]azetidin-3-yl}-1H-1,2,3-triazole-4-carboxylic acid | C11H16N4O4 | 1529035-77-5 | Details |
2,3-Diaminopropionicacid | C3H8N2O2 | 515-94-6 | Details |
(3,3-Difluoropyrrolidin-2-yl)methanol hydrochloride | C5H9F2NO.ClH | 1783608-16-1 | Details |
EBV EBNA-1 IgM Positive Human Plasma | Details |
4-Amino-2,6-diisopropylphenol | C12H19NO | 1988-15-4 | Details |
RAB6C antibody | Details |
Avanafil - Bio-X ? | C23H26ClN7O3 | 330784-47-9 | Details |
5-Isopropyl-2-pyrimidinamine | C7H11N3 | 98432-17-8 | Details |
Adenostemmoic acid D | C20H30O6 | 130217-20-8 | Details |
[4-(N-Methylpyridinium-4-yl)-1,3-thiazol-2-yl]thiolate | C9H8N2S2 | 1427207-46-2 | Details |
2-(2-Methyl-2,3-dihydro-1H-indole-1-carbonyl)cyclohexane-1-carboxylic acid | C17H21NO3 | 1052596-68-5 | Details |
1,3-Dieicosatrienoin | C43H72O5 | 960594-33-6 | Details |
Aztreonam | C13H17N5O8S2 | 78110-38-0 | Details |
4-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)cyclohexane-1-carboxylic acid | C22H23NO4 | 583870-83-1 | Details |
Cyclokievitone | C20H18O6 | 74175-82-9 | Details |
3-[(2-Nitrophenyl)amino]propanoic acid | C9H10N2O4 | 38584-58-6 | Details |
4-[({6-[(tert-Butoxy)carbonyl]-6-azaspiro[2.5]octan-1-yl}({[(9H-fluoren-9-yl)methoxy]carbonyl})amino)methyl]thiophene-2-carboxylic a cid | 2137577-42-3 | Details |
1-Palmitin-3-linolenin | C37H66O5 | 126281-90-1 | Details |
3,4-Dichlorophenylacetonitrile | C8H5Cl2N | 3218-49-3 | Details |
6-Azido-6-deoxy-D-galactose | C6H11N3O5 | 66927-03-5 | Details |
EUCODIS??Lipase 015, screening grade, recombinant, from microbial sources - EL015 | Details |
Tri-N-butyl(trimethylsilylmethyl)tin | C16H38SiSn | 77425-85-5 | Details |
(2S,4S,5S)-1-tert-Butyl 2-methyl 4-hydroxy-5-methylpyrrolidine-1,2-dicarboxylate | C12H21NO5 | 1984825-18-4 | Details |
Roxithromycin EP Impurity C | C37H68N2O13 | 111321-02-9 | Details |
Romidepsin | C24H36N4O6S2 | 128517-07-7 | Details |
5-Bromo-2-methylbenzoic acid | C8H7BrO2 | 79669-49-1 | Details |
Cilnidipine - Bio-X ? | C27H28N2O7 | 132203-70-4 | Details |
GSK 2141795 hydrochloride | C18H17Cl3F2N4O2 | 1047635-80-2 | Details |
8-Bromo-3-methyl-7-(2-oxo-2-phenylethyl)-1H-purine-2,6(3H,7H)-dione | C14H11BrN4O3 | 101072-04-2 | Details |
AMYB antibody | Details |
Dihexylamine | C12H27N | 143-16-8 | Details |
TCP10 antibody | Details |
2-Amino-4-fluoro-5-nitrobenzoic acid | C7H5FN2O4 | 1194097-41-0 | Details |
Methyl 5-chloro-1,3-dimethyl-1H-pyrazole-4-carboxylate | C7H9ClN2O2 | 27006-89-9 | Details |
1,2-Decanediol | C10H22O2 | 1119-86-4 | Details |
HAGH antibody | Details |
2-(N-(5-Methylisoxazol-3-yl)carbamoyl)cyclohexanecarboxylic acid | C12H16N2O4 | 313385-57-8 | Details |
4-(Phenylcarbonyl)phenylboronic acid, pinacol ester | C19H21BO3 | 269410-03-9 | Details |
ME3 antibody | Details |
4-{[3-(Thiophen-3-yl)-1,2,4-oxadiazol-5-yl]methyl}-1,3-thiazol-2-amine | C10H8N4OS2 | 1155056-02-2 | Details |
Rosuvastatin (3R,5R) isomer calcium | C22H30CaFN3O6S | 1422515-55-6 | Details |
2,5-Dichloro-3-fluoroisonicotinic acid | C6H2Cl2FNO2 | 514798-00-6 | Details |
3-Sulfamoylbenzene-1-sulfonyl fluoride | C6H6FNO4S2 | 1334644-12-0 | Details |
2-(5-Methoxythiophen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C11H17BO3S | 596819-12-4 | Details |
2-[(2,4-Dichlorophenyl)methoxy]ethan-1-amine | C9H11Cl2NO | 790626-85-6 | Details |
Silthiofam-des(trimethylsilyl) | C10H13NOS | 1789818-21-8 | Details |
HSPA13 antibody (biotin) | Details |
FNIP1 Antibody | Details |
Lacto-N-neotetraose-GEL | Details |
{[4-(1,3-Dioxaindan-5-yl)-1H-imidazol-2-yl]methyl}(methyl)amine dihydrochloride | C12H14ClN3O2 | 1311314-88-1 | Details |
(2-Phenyloxolan-3-yl)methanol | C11H14O2 | 1525526-13-9 | Details |
1-phenyl-N-(1,2,3-thiadiazol-4-yl)cyclopentane-1-carboxamide | C14H15N3OS | 1023441-52-2 | Details |
1-[3-(3-{1-[2-(Morpholin-4-yl)ethyl]-1H-pyrazol-3-yl}phenyl)phenyl]ethan-1-one | C23H25N3O2 | 1185410-60-9 | Details |
3-Bromopyridine-2-sulfonyl fluoride | C5H3BrFNO2S | 1934834-95-3 | Details |
Methyl 6-methyl-4-nitropyridine-2-carboxylate | C8H8N2O4 | 1206249-95-7 | Details |
3-Amino-2-fluoro-4-methoxybenzoic acid | C8H8FNO3 | 1785489-75-9 | Details |
RPL37 Blocking Peptide | Details |
5,5-Dimethyl-2-(3-oxo-1,3-diphenylpropyl)cyclohexane-1,3-dione | C23H24O3 | 53852-97-4 | Details |
Butyl(methyl)(piperidin-4-ylmethyl)amine | C11H24N2 | 926260-05-1 | Details |
1-{4-Methoxy-3-[(1H-pyrazol-1-yl)methyl]phenyl}ethan-1-amine dihydrochloride | C13H18ClN3O | 1384428-39-0 | Details |
3-Amino-N-(pyrimidin-2-yl)benzene-1-sulfonamide | C10H10N4O2S | 7470-75-9 | Details |
1-(2-Aminoethoxy)-3-tert-butylbenzene hydrochloride | C12H20ClNO | 1306605-41-3 | Details |
2-Methyl-2-(1,3-oxazol-5-yl)propanoic acid | C7H9NO3 | 1781842-07-6 | Details |
MRPL40 antibody | Details |
QARS Blocking Peptide | Details |
Propranolol D-glucuronide D6 | C22H23D6NO8 | Details |
2-(4-Methoxyphenyl)-1-(piperazin-1-yl)ethan-1-one hydrochloride | C13H19ClN2O2 | 1221723-52-9 | Details |
1,3,4-Thiadiazole-2-ethylamine dihydrochloride | C4H9Cl2N3S | 1523571-16-5 | Details |
3-(5-Phenyl-1H-pyrrol-2-yl)-propionic acid | C13H13NO2 | 79720-70-0 | Details |
Carbamic acid | C10H12N2O4 | 84640-31-3 | Details |
2-(((1,3-dioxoindan-2-ylidene)methyl)amino)benzoic acid | C17H11NO4 | 1023505-31-8 | Details |
QRSL1 Blocking Peptide | Details |
2-Methyl-1-[4-(2-methylpropyl)phenyl]propan-1-amine | C14H23N | 847837-44-9 | Details |
Oleic acid-d9 | C18H34O2 | 1809227-37-9 | Details |
STOML2 Blocking Peptide | Details |
[(2-Chlorobenzyl)thio]acetic acid | C9H9ClO2S | 66516-65-2 | Details |
6-Oxa-1-azaspiro[3.4]octane hydrochloride | C6H12ClNO | 1909319-43-2 | Details |
N-(Prop-2-en-1-yl)thiophene-2-sulfonamide | C7H9NO2S2 | 140938-40-5 | Details |
1,2-Dibromo-3-methylbut-2-ene | C5H8Br2 | 17853-42-8 | Details |
4-((tert-Butoxycarbonyl)amino)-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid | C16H21NO4 | 1824346-58-8 | Details |
5-Chloro-2-methoxypyridin-4-amine hydrochloride | C6H8Cl2N2O | 2344679-61-2 | Details |
1-(Piperidin-3-yl)-1H-pyrazole-3-carboxylic acid hydrochloride | C9H14ClN3O2 | 1955556-64-5 | Details |
Dimethyl-1,3-thiazole-2-sulfonamide | C5H8N2O2S2 | 616880-12-7 | Details |
2-[4-(2-{[(tert-Butoxy)carbonyl]amino}ethyl)-1H-1,2,3-triazol-1-yl]acetic acid | C11H18N4O4 | 2138103-08-7 | Details |
Recombinant Human GITR Ligand | Details |
SRD5A3 antibody | Details |
Anti-TNIK antibody - 2mg/mL | Details |
Product Total: Product Page: | ||||
41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 |